Showing 3 of 3 recruiting trials for “Rare carcinoma of small intestine”
Enfortumab Vedotin in Patients With Advanced Small Bowel Adenocarcinoma Refractory or Intolerant to Platinum-based Combination Therapy
Study of NALIRIFOX in Advanced Unresectable Small Bowel Tumors
👨⚕️ Tiago Biachi de Castria, MD, PhD, Moffitt Cancer Center📍 5 sites📅 Started Jun 2025View details ↗
RecruitingNCT06234306 ↗
Molecularly Redefining Small Bowel Adenocarcinoma to Accelerate Precision Patient Care
👨⚕️ Dan Høgdall, MD PhD, Department of Oncology, Copenhagen University Hospital - Herlev and Gentofte📍 3 sites📅 Started Jan 2024View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →